Grifols SA ADR (GRFS) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Grifols SA ADR

NASDAQ | GRFS

7.11

USD

-0.38 (-5.07%)

AT CLOSE (AS OF Apr 3, 2025)

$7.1B

MARKET CAP

P/E Ratio

0.26

EPS

$10

52 Week High

$5.8

52 Week Low

LIFE SCIENCES

Sector

GRFS Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

GRFS Technicals

Tags:

GRFS Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field	Value (EUR)
Gross Profit	$2.3B
Total Revenue	$6.6B
Cost Of Revenue	$4.3B
Costof Goods And Services Sold	$4.3B
Operating Income	$738M
Selling General And Administrative	$1.3B
Research And Development	$331M
Operating Expenses	$1.6B
Investment Income Net	-
Net Interest Income	-$574M
Interest Income	$62M
Interest Expense	$597M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$442M
Income Before Tax	$224M
Income Tax Expense	$43M
Interest And Debt Expense	-
Net Income From Continuing Operations	$138M
Comprehensive Income Net Of Tax	-
Ebit	$740M
Ebitda	$1.2B
Net Income	$59M

Revenue & Profitability

Earnings Performance

GRFS Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2023)

Field	Value (EUR)
Total Assets	$21B
Total Current Assets	$6.5B
Cash And Cash Equivalents At Carrying Value	$530M
Cash And Short Term Investments	$530M
Inventory	$3.5B
Current Net Receivables	-
Total Non Current Assets	$15B
Property Plant Equipment	-
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$2.8B
Intangible Assets Excluding Goodwill	$2.8B
Goodwill	$6.8B
Investments	-
Long Term Investments	$565M
Short Term Investments	$116M
Other Current Assets	$1.5B
Other Non Current Assets	-
Total Liabilities	$13B
Total Current Liabilities	$2.3B
Current Accounts Payable	-
Deferred Revenue	-
Current Debt	-
Short Term Debt	$898M
Total Non Current Liabilities	$11B
Capital Lease Obligations	$1.1B
Long Term Debt	$8.2B
Current Long Term Debt	$791M
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$10B
Other Current Liabilities	$551M
Other Non Current Liabilities	$814M
Total Shareholder Equity	$5.8B
Treasury Stock	-
Retained Earnings	$59M
Common Stock	$120M
Common Stock Shares Outstanding	$679M

yearly Cash Flow (As of Dec 31, 2023)

Field	Value (EUR)
Operating Cashflow	$208M
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$442M
Capital Expenditures	$295M
Change In Receivables	-
Change In Inventory	-$427M
Profit Loss	-
Cashflow From Investment	-
Cashflow From Financing	$186M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$0
Dividend Payout Common Stock	$0
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$0
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$59M

yearly Income Statement (As of Dec 31, 2023)

Field	Value (EUR)
Gross Profit	$2.3B
Total Revenue	$6.6B
Cost Of Revenue	$4.3B
Costof Goods And Services Sold	$4.3B
Operating Income	$738M
Selling General And Administrative	$1.3B
Research And Development	$331M
Operating Expenses	$1.6B
Investment Income Net	-
Net Interest Income	-$574M
Interest Income	$62M
Interest Expense	$597M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$442M
Income Before Tax	$224M
Income Tax Expense	$43M
Interest And Debt Expense	-
Net Income From Continuing Operations	$138M
Comprehensive Income Net Of Tax	-
Ebit	$740M
Ebitda	$1.2B
Net Income	$59M

Dividends

Field	Value
Ex Dividend Date	2021-06-03
Declaration Date	None
Record Date	None
Payment Date	None
Amount	0.359516

GRFS Profile

Grifols SA ADR Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives. The company is headquartered in Barcelona, Spain.

Most Active

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	776,312,724
NVDA	$101.80	-7.81%	$2.68T	338,769,412
INTC	$22.43	2.05%	$95.85B	242,972,129
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	211,931,403

See more →

Symbol	Price	Change %	Market Cap	Volume
JNJ	$159.81	2.86%	$399.65B	13,235,689
PG	$172.39	1.71%	$399.61B	9,393,270
ABBV	$201.64	-1.73%	$364.89B	7,580,327
NVO	$67.12	-1.65%	$308.32B	8,797,694
ABT	$131.63	-0.23%	$228.39B	6,239,225

See more →

Top Gainers

Symbol	Price	Change %	Market Cap	Volume
VCIG	$5.99	1,796.17%	$744.62K	310,904
MKTW	$9.23	1,692.58%	$19.91M	126,841
MRM	$0.69	87.76%	$2.91M	54,062,078
PTIX	$0.42	84.14%	$4.04M	177,332,811
OSRH	$2.47	68.03%	$40.06M	89,499,750

See more →

Top Losers

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,941,899
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
ICCT	$2.07	-56.14%	$9.78M	12,637,345